CP
TMO icon

CenterBook Partners’s Thermo Fisher Scientific TMO Stock Holding History

CenterBook Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Sell
2,564
-1,176
-31% -$565K 0.06% 313
2026
Q1 		$1.84M Buy
3,740
+2,475
+196% +$1.34M 0.1% 250
2025
Q4 		$733K Sell
1,265
-2,526
-67% -$1.43M 0.04% 432
2025
Q3 		$1.84M Buy
3,791
+2,870
+312% +$1.34M 0.09% 269
2025
Q2 		$373K Buy
+921
New +$385K 0.02% 473
2025
Q1 		– Sell
-1,327
Closed -$690K – 600
2024
Q4 		$690K Buy
1,327
+972
+274% +$534K 0.04% 383
2024
Q3 		$220K Sell
355
-2,486
-88% -$1.47M 0.01% 435
2024
Q2 		$1.57M Sell
2,841
-2,233
-44% -$1.28M 0.1% 289
2024
Q1 		$2.95M Buy
5,074
+1,378
+37% +$773K 0.2% 184
2023
Q4 		$1.96M Buy
3,696
+176
+5% +$85.2K 0.24% 149
2023
Q3 		$1.78M Sell
3,520
-1,276
-27% -$680K 0.22% 153
2023
Q2 		$2.5M Buy
4,796
+2,334
+95% +$1.26M 0.31% 110
2023
Q1 		$1.42M Sell
2,462
-312
-11% -$176K 0.2% 163
2022
Q4 		$1.53M Buy
2,774
+1,370
+98% +$726K 0.25% 141
2022
Q3 		$712K Buy
+1,404
New +$786K 0.14% 241

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

CenterBook Partners's TMO Position: Q2 2026 in Review

CenterBook Partners reduced its Thermo Fisher Scientific (TMO) stake by 31% in Q2 2026, selling an estimated $565K and leaving 2,564 shares worth $1.29M. The position accounts for 0.06% of the portfolio, ranked #313.

CenterBook Partners first reported a position in TMO in Q3 2022 and has held it in 15 quarters since. The position peaked at $2.95M in Q1 2024. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • CenterBook Partners held 2,564 shares of Thermo Fisher Scientific worth $1.29M as of Q2 2026.
  • CenterBook Partners sold 1,176 Thermo Fisher Scientific shares in Q2 2026, an estimated $565K.
  • Thermo Fisher Scientific made up 0.06% of CenterBook Partners's portfolio in Q2 2026, its #313 holding.
  • CenterBook Partners first reported a position in Thermo Fisher Scientific in Q3 2022 and has held it in 15 quarters since.
  • CenterBook Partners's Thermo Fisher Scientific position peaked at $2.95M in Q1 2024.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.